Best Stacey Simms Podcasts (2024)

1
What to do when you can't fill your Ozempic or Mounjaro prescription - Advice from an endocrinologist 27:06

1d ago27:06

27:06

Medications like Ozempic and Mounjaro have fundamentally changed the way diabetes is treated. But even if your doctor writes the prescription and your insurance company covers it, getting your hands on the medication is getting harder and harder. We’re talking about what to do if you’re having trouble here – tips if you have to start and stop – and…

1
What is EPI? DIY diabetes pioneer Dana Lewis wants you to know your risk 42:20

3d ago42:20

42:20

DIY Pioneer Dana Lewis was diagnosed with something called EPI – exocrine pancreatic insufficiency a couple of years ago. She’d never heard of it and was shocked to find out diabetes is considered a common co-condition. In fact, 20-30 percent of people with diabetes can end up with EPI. EPI can cause a lot of discomfort and stomach issues – and hea…

1
In the news.. Insulin pen shortage, Omnipod 5 update, once-weekly insulin approved in Canada, and more! 7:59

7d ago7:59

7:59

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: South Africa runs out of insulin pens - and why this could happen anywhere, once-weekly insulin is approved in Canada, update on Omnipod 5 with Dexcom G7 rollout, more older people are getting type 1 but more people are living longer with it, CG…

1
In the news.. Insulin pen shortage, Omnipod 5 update, once-weekly insulin approved in Canada, and more! 7:59

7d ago7:59

7:59

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: South Africa runs out of insulin pens - and why this could happen anywhere, once-weekly insulin is approved in Canada, update on Omnipod 5 with Dexcom G7 rollout, more older people are getting type 1 but more people are living longer with it, CG…

1
The business of diabetes - Scott Strumello's perspective after 50 years of T1D 41:00

12d ago41:00

41:00

Scott Strumello has lived almost 50 years with type 1. Diagnosed as a child in the 70s, he found the online community and started blogging. Scott has a unique perspective – with a background in finance and consulting, he’s a reliable source of what’s happening in earnings calls, legislation, and the business of diabetes. We have a great talk about …

1
What is a diabetologist (and should you see one?) 33:01

16d ago33:01

33:01

Have you heard of a diabetologist? This is a newer specialty in the U-S that may help offset the lack of endocrinologists. Most people with type 2 see a general practitioner and the diabetology certification helps those doctors learn about the latest in diabetes care. We’ll talk about how to find one of these rare experts, why there could be more o…

1
JDRF is now “Breakthrough T1D” - Behind the rebrand (and other changes) 34:03

20d ago34:03

34:03

JDRF… is no more. A rebranding and name change means the organization founded in 1970 by concerned parents will now be known as Breakthrough T1D. You can guess some of the reasons for this change – the “J” for juvenile has long been a turn off for adults living with type 1 – but some of the other reasons are surprising. We’ll do a deep dive into wh…

1
In the News... Dexcom to Apple Watch, Metformin during pregnancy, Mounjaro shortage update... and more! 10:31

22d ago10:31

10:31

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom goes Direct to Watch in the US, Abbott gets FDA okay for its OTC CGM, new study about metformin during pregnancy, an update on semaglutides, JDRF changes its name, and more! Find out more about Moms' Night Out Please visit our Sponsors & …

1
In the News... Dexcom to Apple Watch, Metformin during pregnancy, Mounjaro shortage update... and more! 10:31

22d ago10:31

10:31

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom goes Direct to Watch in the US, Abbott gets FDA okay for its OTC CGM, new study about metformin during pregnancy, an update on semaglutides, JDRF changes its name, and more! We have a monthly newsletter! Sign up today (no spam we promise)…

1
How close are we to glucose-responsive insulin? An update from Sensulin’s CEO 30:18

26d ago30:18

30:18

We’ve been hearing about smart insulin for a long time. This refers to an insulin that would react to glucose levels and adjust by itself with no external device, like a CGM, needed. You’d inject and let the insulin do the work. I’m talking to Sensulin CEO Mike Moradi about where their version of this amazing sounding technology stands, his family …

1
Transforming Diabetes Care: GlucosePATH Makes Personalized Medication Recommendations 35:29

1M ago35:29

35:29

GlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds. It was created by computer scientist Len Testa and endocrinologist Dr. Bradly Eilerman. Len Testa is also co host of the fabulous Disney Dish podcast and the creator of…

1
Disney DAS pass changes, plus GlucosePath & Catalyst studies 38:27

1M ago38:27

38:27

Disney very recently made some changes to their Disability Access Services program – often referred to as a DAS pass at Disney World and Disney Land. We’re going to talk about why this happened, what it means for you, and what else is going on at Disney. Note: this interview was taped BEFORE the changes took place. More about Len Testa's Touring Pl…

1
Insulin and Glucagon in the same pump? Explaining the Beta Bionics - Xeris partnership 38:30

1M ago38:30

38:30

This week, creating a bihormonal pump – using insulin and glucagon in one device - has been the goal of Beta Bionics since before the company even had that name. Now that they’ve launched the insulin-only version of their iLet, we’re getting an update on the dual chambered version. The big news is a new agreement with Xeris to supply that shelf-sta…

1
Inside the class-action lawsuit against insulin pricing, with Attorney Steve Berman 24:55

2M ago24:55

24:55

This week, talking with one of the lawyers bringing a class-action lawsuit against the insulin companies.. a lawsuit that has been inching forward since 2017. It was set to be settled for 500-million dollars and a four year price cap, but then judge said no. Attorney Steve Berman will talk about that last minute surprise, why he's still going forwa…

1
Inside the class-action lawsuit against insulin pricing, with Attorney Steve Berman 26:45

2M ago26:45

26:45

This week, talking with one of the lawyers bringing a class-action lawsuit against the insulin companies.. a lawsuit that has been inching forward since 2017. It was set to be settled for 500-million dollars and a four year price cap, but then judge said no. Attorney Steve Berman will talk about that last minute surprise, why he’s still going forwa…

1
In the News.. T1D increasing in older adults, new iCGM designation, low BG prevention tested, and more! 7:48

2M ago7:48

7:48

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: more older adults are being diagnosed with type 1 and people with T1D are living longer, Eversense gets iCGM designation, new drug to prevent low BG is being tested, Tandem diabetes app recall, and more! Find out more about Moms' Night Out Pleas…

1
In the News.. T1D increasing in older adults, new iCGM designation, low BG prevention tested, and more! 7:48

2M ago7:48

7:48

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: more older adults are being diagnosed with type 1 and people with T1D are living longer, Eversense gets iCGM designation, new drug to prevent low BG is being tested, Tandem diabetes app recall, and more! Find out more about Moms' Night Out Pleas…

1
"You are raising fearless children" journalist Madison Carter speaks at Moms' Night Out Charlotte 58:04

2M ago58:04

58:04

This week, what growing up with diabetes meant for career choices, financial decisions, and family relationships. Madison Carter is a local news anchor who makes T1D very visible – and she does not hold back. She’s generous with incredible insight into how she was raised, sacrifices her family made and what her mom and dad have to say now. This pod…

1
Diabetes in the hospital - what patients need to know 33:27

2M ago33:27

33:27

We're taking a close up look at hospital care when you have type 2 – from the people who grade the hospitals. 30% of patients admitted for acute care have diabetes. But many hospitals aren’t prepared or have staff trained to take care of this. My guests – from the watchdog group Leapfrog and from the ADA, will talk about what’s been doing right and…

1
“As active as I want to be” - Dianne Mattiace uses Eversense CGM to thrive with T1D in her 70s 43:03

2M ago43:03

43:03

This week, managing type 1 diabetes into your 70s is a bit of uncharted waters.. While thankfully more and more people are living long with T1D, that wasn’t always the case. I’m taking to Dianne Mattiace who is in her early 70s and was diagnosed as an adult, 30 years ago. She was the first person in the US to use the Eversense CGM when it was appro…

1
In the News... Ingredients linked to T2D, genetic T1D research, new SGLT-2 guidelines and more! 5:51

2M ago5:51

5:51

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study links emulsifiers, a common ingrediant, to type 2 diabetes, reserachers map out the pancreas in a new way that's already yielding new information, new guidliens about using GLP-1s and SGLT-2 medications with exisiting oral meds, gene…

1
In the News... Ingredients linked to T2D, genetic T1D research, new SGLT-2 guidelines and more! 5:51

2M ago5:51

5:51

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study links emulsifiers, a common ingrediant, to type 2 diabetes, reserachers map out the pancreas in a new way that's already yielding new information, new guidliens about using GLP-1s and SGLT-2 medications with exisiting oral meds, gene…

1
“How can we continue to move T1D to the background?” Medtronic’s Dr. Jennifer McVean 46:08

2M ago46:08

46:08

This week, catching up with Medtronic’s Senior Director of Global Medical Affairs Dr. Jennifer McVean. It’s been one year since the 780G was approved in the US, what does the device – and its seven-day infusion set – look like in the real world. Plus, we have a big discussion about the future of type 1 diabetes – Dr. McVean has lead some significan…

1
Dr. Nina Cash on becoming a Sports Illustrated Swimsuit Model at 57, with type 2 diabetes 32:07

2M ago32:07

32:07

We’re talking to a sports illustrated swimsuit model – who lives with type 2! Nina Cash is also in her late 50s – so being a swimsuit model wasn’t something she really thought was in the cards – she spent her career in education and retired as a University Dean. She’ll tell us the story of how the SI gig happened and why she’s park of the rookie cl…

1
Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin 44:03

3M ago44:03

44:03

This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that twists off – with very different software – Tidepool Loop. The company behind this pump – they’re called Sequel - wants to be different as well, hoping to offer solutions to bigger issue than basal and bolus rates. It’s …

1
In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more! 9:11

3M ago9:11

9:11

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom launches direct-to-watch with the G7 in the UK and Ireland, more studies looking at heart benefits with Wegovy and diabetes, a new T1D study investigating an injectable to prevent overnight hypoglycemia, lobbying for Levimir, a ChatGPT di…

1
In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more! 9:11

3M ago9:11

9:11

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom launches direct-to-watch with the G7 in the UK and Ireland, more studies looking at heart benefits with Wegovy and diabetes, a new T1D study investigating an injectable to prevent overnight hypoglycemia, lobbying for Levimir, a ChatGPT di…

1
The FDA took down this teen’s free bolus calculator. He needs your help to bring it back. 33:49

3M ago33:49

33:49

There used to be a lot of bolus calculators in the app store, maybe you’ve used one and haven’t updated it in a while. Don’t try now.. it’s likely been pulled. Apple and the FDA are cracking down on this types of tools – no unreasonable, right? But surely there are more coming.. how hard can it be to create a simple insulin bolus calculator that’s …

1
Diabetes Education is boring! This group wants YOUR input to make it better. 28:14

3M ago28:14

28:14

Diabetes education is boring. Right? Yeah educators think so too. So what can we do to make it better? We’re talking about a new effort to talk to people with diabetes and find out what works for you. I’m talking to Dr Bill Polonksy from the Behavioral Diabetes Institute This podcast is not intended as medical advice. If you have those kinds of que…

1
Diabetes Technology: Expectation vs Reality with Dr. Stephen Ponder 45:54

3M ago45:54

45:54

Diabetes technology is getting better and better. We have automated insulin systems that link pumps and CGMs, and smart insulin pens that have precise calculations and reminders. It’s been quite the evolution over the past few years! But outcomes – time in range, A1Cs, aren’t exactly where experts thought they might be. I’m talking to Dr. Stephen P…

1
In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more! 10:35

3M ago10:35

10:35

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: a new study shows that drugs like Ozempic can be produced for just a few dollars, we upate the insulin vial shortage Lilly announced, a new pump has been FDA cleared, a genetically modified cow can product human insulin, and more! Transcript and…

1
In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more! 10:35

3M ago10:35

10:35

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: a new study shows that drugs like Ozempic can be produced for just a few dollars, we upate the insulin vial shortage Lilly announced, a new pump has been FDA cleared, a genetically modified cow can product human insulin, and more! Transcript and…

Podcasts Worth a Listen

Stacey Simms Podcasts

Podcasts Worth a Listen

Quick Reference Guide